Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uganda | 44 | 2024 | 1353 | 2.540 |
Why?
|
HIV Infections | 34 | 2024 | 17542 | 1.490 |
Why?
|
Carotid Artery Diseases | 5 | 2021 | 872 | 1.160 |
Why?
|
Rural Population | 13 | 2024 | 2321 | 1.020 |
Why?
|
HIV Seronegativity | 3 | 2021 | 209 | 0.800 |
Why?
|
Dyspepsia | 1 | 2022 | 116 | 0.770 |
Why?
|
Anti-HIV Agents | 7 | 2021 | 4567 | 0.750 |
Why?
|
Hypertension | 8 | 2022 | 8615 | 0.710 |
Why?
|
Fatty Acid-Binding Proteins | 2 | 2019 | 292 | 0.680 |
Why?
|
Esophageal Neoplasms | 3 | 2022 | 1661 | 0.670 |
Why?
|
Helicobacter pylori | 1 | 2022 | 380 | 0.650 |
Why?
|
HIV Long-Term Survivors | 1 | 2020 | 140 | 0.650 |
Why?
|
Helicobacter Infections | 1 | 2022 | 390 | 0.640 |
Why?
|
Biomass | 1 | 2019 | 135 | 0.620 |
Why?
|
Urban Health | 1 | 2021 | 533 | 0.620 |
Why?
|
Heating | 1 | 2019 | 103 | 0.620 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2018 | 281 | 0.590 |
Why?
|
Cooking | 1 | 2019 | 327 | 0.550 |
Why?
|
Anti-Retroviral Agents | 5 | 2019 | 1787 | 0.540 |
Why?
|
HIV Seropositivity | 1 | 2021 | 963 | 0.520 |
Why?
|
Preventive Health Services | 1 | 2020 | 570 | 0.480 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2016 | 425 | 0.470 |
Why?
|
Decision Support Techniques | 3 | 2018 | 2006 | 0.450 |
Why?
|
Cardiology Service, Hospital | 1 | 2014 | 242 | 0.400 |
Why?
|
Interleukin-6 | 3 | 2019 | 3227 | 0.400 |
Why?
|
Education, Medical, Continuing | 1 | 2017 | 829 | 0.400 |
Why?
|
Air Pollution, Indoor | 1 | 2019 | 931 | 0.380 |
Why?
|
C-Reactive Protein | 3 | 2019 | 3851 | 0.350 |
Why?
|
Deglutition Disorders | 1 | 2016 | 640 | 0.350 |
Why?
|
Heart Failure | 4 | 2022 | 11877 | 0.340 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1549 | 0.340 |
Why?
|
Antihypertensive Agents | 2 | 2016 | 2030 | 0.340 |
Why?
|
Risk Factors | 21 | 2022 | 74886 | 0.340 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 2815 | 0.340 |
Why?
|
Antigens, CD | 3 | 2018 | 4032 | 0.320 |
Why?
|
Hospitalization | 4 | 2018 | 10815 | 0.310 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2020 | 951 | 0.290 |
Why?
|
Quality of Life | 6 | 2024 | 13485 | 0.270 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 26325 | 0.270 |
Why?
|
Blood Pressure | 3 | 2019 | 8531 | 0.260 |
Why?
|
Prevalence | 12 | 2024 | 15851 | 0.260 |
Why?
|
Case-Control Studies | 7 | 2021 | 22254 | 0.260 |
Why?
|
Lower Extremity | 1 | 2014 | 1217 | 0.260 |
Why?
|
Self Report | 2 | 2019 | 3773 | 0.250 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 5886 | 0.250 |
Why?
|
Echocardiography | 1 | 2017 | 5042 | 0.240 |
Why?
|
Loneliness | 2 | 2024 | 211 | 0.240 |
Why?
|
Blood Pressure Determination | 2 | 2019 | 646 | 0.230 |
Why?
|
Medication Adherence | 1 | 2016 | 2191 | 0.230 |
Why?
|
Feces | 2 | 2022 | 1508 | 0.230 |
Why?
|
Middle Aged | 31 | 2024 | 223233 | 0.220 |
Why?
|
Adult | 28 | 2022 | 223317 | 0.220 |
Why?
|
Male | 39 | 2024 | 364203 | 0.220 |
Why?
|
Kenya | 3 | 2021 | 757 | 0.220 |
Why?
|
Alcohol Drinking | 1 | 2016 | 4045 | 0.210 |
Why?
|
Female | 40 | 2024 | 396660 | 0.210 |
Why?
|
Humans | 55 | 2024 | 767040 | 0.210 |
Why?
|
Peripheral Arterial Disease | 1 | 2014 | 1304 | 0.200 |
Why?
|
Inflammation | 2 | 2019 | 10869 | 0.200 |
Why?
|
Africa South of the Sahara | 3 | 2020 | 751 | 0.200 |
Why?
|
Clinical Competence | 1 | 2017 | 4859 | 0.190 |
Why?
|
Lung Diseases, Obstructive | 1 | 2022 | 309 | 0.180 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2019 | 1902 | 0.180 |
Why?
|
Smoking | 2 | 2022 | 9081 | 0.180 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4049 | 0.180 |
Why?
|
Cardiovascular Diseases | 4 | 2022 | 15645 | 0.180 |
Why?
|
Africa, Western | 1 | 2020 | 160 | 0.180 |
Why?
|
Rural Health | 2 | 2019 | 302 | 0.180 |
Why?
|
Risk Assessment | 6 | 2021 | 24299 | 0.170 |
Why?
|
Communicable Disease Control | 2 | 2023 | 856 | 0.170 |
Why?
|
Eclampsia | 1 | 2020 | 61 | 0.170 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 89 | 0.160 |
Why?
|
Charcoal | 1 | 2019 | 67 | 0.160 |
Why?
|
Coal | 1 | 2019 | 122 | 0.160 |
Why?
|
Wood | 1 | 2019 | 94 | 0.160 |
Why?
|
Cohort Studies | 13 | 2024 | 41718 | 0.160 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 1044 | 0.150 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15424 | 0.150 |
Why?
|
Maternal Mortality | 1 | 2020 | 310 | 0.140 |
Why?
|
Nigeria | 1 | 2020 | 781 | 0.140 |
Why?
|
Aged | 18 | 2024 | 171319 | 0.140 |
Why?
|
Stillbirth | 1 | 2020 | 381 | 0.140 |
Why?
|
Antigens, Bacterial | 1 | 2022 | 1148 | 0.140 |
Why?
|
Fasting | 2 | 2020 | 1607 | 0.140 |
Why?
|
Longitudinal Studies | 4 | 2022 | 14766 | 0.140 |
Why?
|
Glasgow Coma Scale | 1 | 2018 | 574 | 0.140 |
Why?
|
Tanzania | 1 | 2020 | 1406 | 0.130 |
Why?
|
Carbon Monoxide | 1 | 2019 | 559 | 0.130 |
Why?
|
Developing Countries | 2 | 2019 | 2911 | 0.130 |
Why?
|
Acute Disease | 2 | 2018 | 7236 | 0.130 |
Why?
|
Prognosis | 4 | 2020 | 29963 | 0.120 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2020 | 529 | 0.120 |
Why?
|
Body Mass Index | 4 | 2022 | 13048 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2019 | 744 | 0.110 |
Why?
|
Hematoma | 1 | 2018 | 766 | 0.110 |
Why?
|
Prospective Studies | 5 | 2021 | 54886 | 0.110 |
Why?
|
Patient Dropouts | 1 | 2016 | 411 | 0.110 |
Why?
|
Ankle Brachial Index | 1 | 2014 | 163 | 0.110 |
Why?
|
Viral Load | 2 | 2020 | 3385 | 0.110 |
Why?
|
Atherosclerosis | 2 | 2022 | 3418 | 0.110 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 621 | 0.110 |
Why?
|
Life Expectancy | 1 | 2020 | 1248 | 0.100 |
Why?
|
International Cooperation | 1 | 2019 | 1434 | 0.100 |
Why?
|
Gastroenterology | 1 | 2019 | 593 | 0.100 |
Why?
|
Registries | 2 | 2018 | 8351 | 0.100 |
Why?
|
Spirometry | 3 | 2022 | 928 | 0.100 |
Why?
|
Needs Assessment | 1 | 2018 | 1141 | 0.100 |
Why?
|
Aftercare | 1 | 2018 | 915 | 0.100 |
Why?
|
Reproducibility of Results | 3 | 2022 | 20169 | 0.100 |
Why?
|
Carotid Arteries | 3 | 2022 | 934 | 0.100 |
Why?
|
Forced Expiratory Volume | 3 | 2022 | 1830 | 0.090 |
Why?
|
Lung | 2 | 2022 | 10076 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2144 | 0.090 |
Why?
|
Health Facilities | 1 | 2016 | 578 | 0.090 |
Why?
|
Health Resources | 1 | 2017 | 948 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2017 | 2350 | 0.090 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 836 | 0.090 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1255 | 0.090 |
Why?
|
Cholesterol, LDL | 1 | 2020 | 2392 | 0.090 |
Why?
|
Incidence | 3 | 2020 | 21526 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2022 | 14672 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2016 | 888 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2783 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2018 | 4405 | 0.080 |
Why?
|
Time Factors | 2 | 2021 | 40154 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1882 | 0.070 |
Why?
|
Health Policy | 1 | 2020 | 2698 | 0.070 |
Why?
|
Mass Screening | 2 | 2020 | 5456 | 0.070 |
Why?
|
Cause of Death | 1 | 2018 | 3717 | 0.070 |
Why?
|
Cerebral Hemorrhage | 1 | 2018 | 2655 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3387 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3931 | 0.070 |
Why?
|
Depression | 2 | 2024 | 8234 | 0.070 |
Why?
|
Health Status | 1 | 2020 | 4091 | 0.070 |
Why?
|
Body Weight | 1 | 2017 | 4627 | 0.070 |
Why?
|
Pandemics | 2 | 2023 | 8736 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2817 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2018 | 2085 | 0.070 |
Why?
|
Qualitative Research | 3 | 2022 | 3139 | 0.060 |
Why?
|
Respiratory Function Tests | 2 | 2022 | 1695 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2019 | 3986 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12069 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7848 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2019 | 4546 | 0.060 |
Why?
|
Blood Glucose | 1 | 2019 | 6421 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4746 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3414 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9660 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13646 | 0.060 |
Why?
|
Hospital Mortality | 2 | 2014 | 5345 | 0.050 |
Why?
|
Lipids | 1 | 2014 | 3322 | 0.050 |
Why?
|
Sexual Behavior | 2 | 2024 | 2196 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3253 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 2 | 2018 | 2586 | 0.050 |
Why?
|
HIV-1 | 1 | 2019 | 6951 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12790 | 0.040 |
Why?
|
Sex Factors | 3 | 2019 | 10622 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15925 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6573 | 0.040 |
Why?
|
Sepsis | 1 | 2014 | 2605 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9746 | 0.040 |
Why?
|
Diastole | 1 | 2022 | 784 | 0.040 |
Why?
|
Vital Capacity | 1 | 2022 | 996 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4593 | 0.040 |
Why?
|
Logistic Models | 1 | 2014 | 13284 | 0.040 |
Why?
|
Public-Private Sector Partnerships | 1 | 2019 | 123 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 12250 | 0.040 |
Why?
|
Community-Institutional Relations | 1 | 2019 | 209 | 0.040 |
Why?
|
Limit of Detection | 1 | 2018 | 271 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11923 | 0.040 |
Why?
|
CpG Islands | 1 | 2022 | 1206 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2018 | 507 | 0.040 |
Why?
|
South Africa | 1 | 2022 | 1873 | 0.030 |
Why?
|
Adolescent | 2 | 2022 | 89046 | 0.030 |
Why?
|
HIV | 1 | 2023 | 1591 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2024 | 1344 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2018 | 554 | 0.030 |
Why?
|
Lost to Follow-Up | 1 | 2016 | 124 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2019 | 579 | 0.030 |
Why?
|
Biostatistics | 1 | 2016 | 162 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2276 | 0.030 |
Why?
|
Public Sector | 1 | 2016 | 266 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2020 | 1816 | 0.030 |
Why?
|
Comorbidity | 2 | 2018 | 10582 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2020 | 1741 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3621 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2429 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1298 | 0.030 |
Why?
|
Bacteria | 1 | 2024 | 2212 | 0.030 |
Why?
|
Respiratory Rate | 1 | 2014 | 179 | 0.030 |
Why?
|
Triglycerides | 1 | 2020 | 2444 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12536 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1512 | 0.020 |
Why?
|
Gestational Age | 1 | 2020 | 3618 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2505 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2936 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4247 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2972 | 0.020 |
Why?
|
Anxiety | 1 | 2024 | 4670 | 0.020 |
Why?
|
United States | 1 | 2017 | 72971 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 59548 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6331 | 0.020 |
Why?
|
Sleep | 1 | 2024 | 4816 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2519 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7210 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4426 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3618 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3561 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3883 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5537 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 6000 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12823 | 0.020 |
Why?
|
Electrocardiography | 1 | 2019 | 6409 | 0.020 |
Why?
|
Aging | 1 | 2024 | 8729 | 0.020 |
Why?
|
Young Adult | 2 | 2022 | 59980 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5519 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4209 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18401 | 0.010 |
Why?
|
Cytokines | 1 | 2015 | 7446 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26396 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 30238 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20741 | 0.010 |
Why?
|
Child | 1 | 2022 | 80771 | 0.010 |
Why?
|
Concepts
(223)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_